Cargando…
Integrated Network Pharmacology and Comprehensive Bioinformatics Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula for Treatment of Comorbidity With Alzheimer’s Disease and Depression
Background: The Yizhiqinxin formula (YZQX) has been used to treat Alzheimer’s disease (AD) or major depression disorder (MDD). However, its specific underlying mechanisms and therapeutic targets remain unclear. Methods: The ingredients and putative targets of YZQX were screened using the TCMSP and D...
Autores principales: | Zhang, Tingting, Wei, Wei, Chang, Surui, Liu, Nanyang, Li, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081443/ https://www.ncbi.nlm.nih.gov/pubmed/35548356 http://dx.doi.org/10.3389/fphar.2022.853375 |
Ejemplares similares
-
Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula on Alzheimer’s Disease: Coupling Network Pharmacology with GEO Database
por: Zhang, Tingting, et al.
Publicado: (2020) -
Comparison of Yizhiqingxin formula extraction methods and their pharmacodynamic differences
por: Wei, Wei, et al.
Publicado: (2023) -
Yizhiqingxin Formula Alleviates Cognitive Deficits and Enhances Autophagy via mTOR Signaling Pathway Modulation in Early Onset Alzheimer’s Disease Mice
por: Yang, Yang, et al.
Publicado: (2019) -
Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis
por: Zhang, Tingting, et al.
Publicado: (2020) -
Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma
por: Guo, Wei, et al.
Publicado: (2019)